- Previous Close
0.3875 - Open
0.3870 - Bid --
- Ask --
- Day's Range
0.3810 - 0.3940 - 52 Week Range
0.3415 - 0.6330 - Volume
289,616 - Avg. Volume
150,983 - Market Cap (intraday)
24.322M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date Oct 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.90
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
www.maunakeatech.comRecent News: ALMKT.PA
View MorePerformance Overview: ALMKT.PA
Trailing total returns as of 7/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALMKT.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALMKT.PA
View MoreValuation Measures
Market Cap
24.07M
Enterprise Value
45.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.30
Price/Book (mrq)
--
Enterprise Value/Revenue
4.38
Enterprise Value/EBITDA
18.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-33.80%
Return on Assets (ttm)
-16.63%
Return on Equity (ttm)
--
Revenue (ttm)
11.03M
Net Income Avi to Common (ttm)
-3.73M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
8.01M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.1M